Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001401225-15-000003

Options or other derivatives

  • CFO disposed of 100,000 shares (code E)

From the SEC's structured data for this filing

Trades in this filing

Bhullar Baljinder · CFO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-09-21 Other disposition : show line 1 in the form Warrants −100,000 $0.25 $25,000 0 D
Loading xslF345X03/primary_doc.xml…